The Healthcare Confidential Podcast | Episode 44 "Anti-Covid Nasal and Throat Spray" Theresa Jacobellis |
Professor Mart Ustav is part of a team of researchers from the University of Tartu in Estonia who have developed SARS COV-2 neutralizing antibodies by immunizing the pregnant cows on the third trimester with the spike protein antigen. With a consortium of five partners: Icosagen AS, ChemiPharm AS, OÜ Teadus & Tegu, Tartu University and University of Life Sciences (Agricultural University), the team developed a nasal and throat spray that works for 3 – 4 hours to neutralize SARS-CoV-2, the Covid-19 virus, in the nose and throat, effectively blocking infection. The spray is another line of defense against the virus that causes Covid-19 and may be particularly useful in protecting those who may not be immunized for religious reasons or due to insufficient immune systems. The product is being made available without a prescription in Estonia.
The Take-Away: If the spray proves effective commercially, there are implications for using this delivery system to prevent the spread of other respiratory viruses such as those that cause the flu and the common cold.
Learn more: Read more about this project here: https://www.ut.ee/en/news/spray-created-estonia-may-help-prevent-corona-infection or visit www.icosagen.com.